Natriuretic Peptides As A Marker of Left Ventricular Diastolic Dysfunction in Patients With Obesity and Hypertension: Relationship With Doppler Tissue Imaging
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F10%3A00046870" target="_blank" >RIV/00216224:14110/10:00046870 - isvavai.cz</a>
Výsledek na webu
—
DOI - Digital Object Identifier
—
Alternativní jazyky
Jazyk výsledku
čeština
Název v původním jazyce
Natriuretic Peptides As A Marker of Left Ventricular Diastolic Dysfunction in Patients With Obesity and Hypertension: Relationship With Doppler Tissue Imaging
Popis výsledku v původním jazyce
Natriuretic peptide (NP) increased early in patients with left ventricular (LV) systolic dysfunction, but early markers of HF development in patients with obesity and hypertension (HT) and LV diastolic dysfunction (DD) are already not very well known. Methods: 118 (56 years, 62 men) consecutive HT pts (stage I and II) with obesity using the value of 30 of body mass Index (BMI) as a cut-off was divided into two groups: A with BMI<30 (n = 56) and B with BMI>30 (n = 62). LV function was assessed by natriuretic peptide plasma levels (BNP, NT pro BNP). Relative wall thickness, cardiac mass, LV volumes and ejection fraction, velocity of early and late diastolic LV filling maximal velocity (E, A), E/A ratio, deceleration E time from transmitral Doppler,and pulsed doppler tissue imaging of velocities of mitral annular movements (Sm, Em, Am) were calculated by echo. Results: Pts revealed normal systolic function of the LV and the same degrese of LVH (61,19 versus 63,4 g/m2,7).
Název v anglickém jazyce
Natriuretic Peptides As A Marker of Left Ventricular Diastolic Dysfunction in Patients With Obesity and Hypertension: Relationship With Doppler Tissue Imaging
Popis výsledku anglicky
Natriuretic peptide (NP) increased early in patients with left ventricular (LV) systolic dysfunction, but early markers of HF development in patients with obesity and hypertension (HT) and LV diastolic dysfunction (DD) are already not very well known. Methods: 118 (56 years, 62 men) consecutive HT pts (stage I and II) with obesity using the value of 30 of body mass Index (BMI) as a cut-off was divided into two groups: A with BMI<30 (n = 56) and B with BMI>30 (n = 62). LV function was assessed by natriuretic peptide plasma levels (BNP, NT pro BNP). Relative wall thickness, cardiac mass, LV volumes and ejection fraction, velocity of early and late diastolic LV filling maximal velocity (E, A), E/A ratio, deceleration E time from transmitral Doppler,and pulsed doppler tissue imaging of velocities of mitral annular movements (Sm, Em, Am) were calculated by echo. Results: Pts revealed normal systolic function of the LV and the same degrese of LVH (61,19 versus 63,4 g/m2,7).
Klasifikace
Druh
O - Ostatní výsledky
CEP obor
FA - Kardiovaskulární nemoci včetně kardiochirurgie
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
Z - Vyzkumny zamer (s odkazem do CEZ)<br>V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Ostatní
Rok uplatnění
2010
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů